Pharmacological management of non-specific chronic low back pain Ft. Dr. Raju Vaishya

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2023-06-07 03:30 GMT | Update On 2023-06-07 10:14 GMT

Nonspecific chronic low back pain (NCLBP) is the single most common cause of pain and disability in industrialized countries and a common cause for consultation in primary care. The world population of adults aged 60 years or older is expected to double by 2050, and NCLBP might become a major public health burden worldwide. The prevalence of NCLPB in women is double compared to men.

A paper was recently published in the journal BMC Musculoskeletal Disorders titled 'Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain' that looks at the management of NCLBP with various medications.

So to discuss this study in detail, Medical Dialogues interviewed one of the authors of the research paper Dr. (Prof) Raju Vaishya. Dr. (Prof) Raju Vaishya is a renowned Orthopedics and joint replacement surgeon having an experience of more than 35 years. He is currently a senior consultant at Indraprastha Apollo Hospital, New Delhi. His interest lies in Knee & Hip Surgery (Total Joint Replacement &; Arthroscopic Surgery), Regenerative therapy in orthopedics, Arthroscopic shoulder surgery, Arthritis & Osteoporosis, and research & publications.

Reference:

Migliorini, F., Vaishya, R., Pappalardo, G. et al. Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain. BMC Musculoskelet Disord 24, 432 (2023). https://doi.org/10.1186/s12891-023-06537-0

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Isra Zaman

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Pharmacological management of non-specific chronic low back pain Ft. Dr. Raju Vaishya

Similar News

Yogurt Shows Limited Benefits for Bone Strength, New Study Finds

Gout Tied to Elevated 10-Year Risk of Heart Attack and Stroke, Study Reveals

These Simple, Non-Drug Treatments Outperform High-Tech Options for Knee Pain Relief: Study Suggests

How Everyday Microplastics Could Be Impacting Your Bone Health? Study Sheds Light

Acupuncture May Ease Chronic Back Pain and Boost Function in Older Adults: Study Shows

Want to Prevent Back Pain? Walk for This Long Every Day: Study Suggests

Skipping Breakfast And Eating Late Linked To Increased Osteoporosis Risk: Study

Personalized Therapy May Offer Lasting Relief for Chronic Back Pain: Study Finds